JPH05112593A - New tetraphenylporphyrin glycoside - Google Patents
New tetraphenylporphyrin glycosideInfo
- Publication number
- JPH05112593A JPH05112593A JP3301053A JP30105391A JPH05112593A JP H05112593 A JPH05112593 A JP H05112593A JP 3301053 A JP3301053 A JP 3301053A JP 30105391 A JP30105391 A JP 30105391A JP H05112593 A JPH05112593 A JP H05112593A
- Authority
- JP
- Japan
- Prior art keywords
- lactose
- reaction
- glycoside
- added
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930182470 glycoside Natural products 0.000 title claims abstract description 18
- -1 tetraphenylporphyrin glycoside Chemical class 0.000 title claims description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 8
- 239000008101 lactose Substances 0.000 claims abstract description 8
- 150000002338 glycosides Chemical class 0.000 claims abstract description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 abstract description 15
- 238000006243 chemical reaction Methods 0.000 abstract description 10
- 229960001375 lactose Drugs 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 6
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract description 3
- 238000004440 column chromatography Methods 0.000 abstract description 3
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 abstract description 2
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 229960001021 lactose monohydrate Drugs 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 239000002243 precursor Substances 0.000 abstract description 2
- 239000001632 sodium acetate Substances 0.000 abstract description 2
- 235000017281 sodium acetate Nutrition 0.000 abstract description 2
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract description 2
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 125000003147 glycosyl group Chemical group 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 159000000000 sodium salts Chemical class 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical class N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 description 6
- 238000010189 synthetic method Methods 0.000 description 6
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N Xylose Natural products O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 150000002016 disaccharides Chemical group 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 238000002428 photodynamic therapy Methods 0.000 description 2
- 150000004032 porphyrins Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YBNLEKXVGHTVEN-GJYFPVOQSA-N C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C1=C(C=CC=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 Chemical compound C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C1=C(C=CC=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 YBNLEKXVGHTVEN-GJYFPVOQSA-N 0.000 description 1
- GFBVTAXEKLBCJW-GJYFPVOQSA-N C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C1=CC=C(C=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 Chemical compound C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C1=CC=C(C=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 GFBVTAXEKLBCJW-GJYFPVOQSA-N 0.000 description 1
- LWXTXSPQTBTBSH-GJYFPVOQSA-N C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C=1C=C(C=CC1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 Chemical compound C1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)C=1C=C(C=CC1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2 LWXTXSPQTBTBSH-GJYFPVOQSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- BGOFCVIGEYGEOF-UJPOAAIJSA-N helicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C=O BGOFCVIGEYGEOF-UJPOAAIJSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 150000004033 porphyrin derivatives Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、水に対して優れた溶解
性を示す新規な二糖が結合したテトラフェニルポルフィ
ン配糖体に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tetraphenylporphine glycoside having a novel disaccharide bonded thereto, which exhibits excellent solubility in water.
【0002】[0002]
【従来の技術】テトラフェニルポルフィンは、従来より
ヘモグロビンあるいはクロロフィル等のポルフィリン骨
格を有する物質のモデル化合物として利用されてきた。
しかしながら、テトラフェニルポルフィン自体は有機溶
媒に難溶であり、水には不溶である。そのため、溶解性
を改良するためにフェニル基にアルキル基、スルホン酸
基、カルボキシル基、アミノ基を導入する等の工夫がな
されている。2. Description of the Related Art Tetraphenylporphine has been conventionally used as a model compound for a substance having a porphyrin skeleton such as hemoglobin or chlorophyll.
However, tetraphenylporphine itself is sparingly soluble in organic solvents and insoluble in water. Therefore, in order to improve the solubility, various measures such as introducing an alkyl group, a sulfonic acid group, a carboxyl group or an amino group into the phenyl group have been made.
【0003】一方これまでにテトラフェニルポルフィン
配糖体としては、J.Am.Chem.Soc.,111,9125(1989) にヘ
リシンを原料として合成した例があるだけである。これ
はテトラフェニルポルフィンのフェニル基のオルソ位に
グルコースが結合したものであり、水に溶解するという
記述があるが実際上は任意に高濃度にまで溶解すること
は困難である。また、先に本発明者らが出願している単
糖であるところのキシロースが結合したテトラフェニル
ポルフィンがあるが、これも水には難溶であり水溶性と
は言えない(特願平3−219152号)。On the other hand, as a tetraphenylporphine glycoside, up to now, there is only an example in J. Am. Chem. Soc., 111, 9125 (1989), in which helicine was synthesized as a raw material. It is described that glucose is bound to the ortho position of the phenyl group of tetraphenylporphine, and it is soluble in water, but in practice it is difficult to dissolve it to arbitrarily high concentrations. In addition, there is xylose-bound tetraphenylporphine, which is a monosaccharide that the present inventors applied for earlier, but it is also poorly soluble in water and cannot be said to be water-soluble (Japanese Patent Application No. 3). -219152).
【0004】さて、最近ではテトラフェニルポルフィン
あるいはその誘導体が超高密度光記録を可能ならしめる
フォトケミカルホールバーニングの記録材料として注目
されている。しかしながら、現段階では、このフォトケ
ミカルホールバーニング記録は極低温でのみ可能であ
り、そのため動作温度の高温化が実用上のひとつの課題
となっている。これまでに、高温動作に成功した例は少
なく、Jpn.J.Appl.Phys.,27,L1304(1988) およびAppl.P
hys.Lett.,53,935(1988)が有るだけである。これら高温
動作に成功した要因として、色素分子とそれを取巻くマ
トリックスとの間の水素結合によるものと考えられてお
り、さらに高温動作を可能ならしめる、より優れた記録
材料の開発が待たれている。By the way, recently, tetraphenylporphine or its derivative has been attracting attention as a recording material for photochemical hole burning which enables ultra-high density optical recording. However, at this stage, this photochemical hole burning recording is possible only at an extremely low temperature, so that raising the operating temperature is one of the practical problems. Up to now, there have been few successful cases of high temperature operation, Jpn.J.Appl.Phys., 27, L1304 (1988) and Appl.P.
There is only hys.Lett., 53,935 (1988). The success of these high temperature operations is believed to be due to hydrogen bonding between the dye molecules and the surrounding matrix, and the development of superior recording materials that enable higher temperature operations is awaited. ..
【0005】また、近年フォトダイナミックセラピーの
治療材料としてもポルフィン誘導体は使用されており、
臨床例も幾つか報告されている。この場合、体内に取込
まれるまでに前述したように溶解性の点で非常に遅く、
治療に要する時間がかかり患者に負担がかかるといった
欠点がある。ポルフィン誘導体が水溶性である場合に
は、極めて優れた治療効果が期待できる。さらに、ポル
フィリン誘導体の金属錯体は有機合成反応触媒としても
種々検討されているが、溶解性が改善されることで応用
範囲が飛躍的に広がる可能性がある。In recent years, porphine derivatives have been used as a therapeutic material for photodynamic therapy.
Some clinical cases have been reported. In this case, it is very slow in terms of solubility until it is taken up by the body,
There is a drawback in that it takes a long time for treatment and burdens the patient. When the porphine derivative is water-soluble, an extremely excellent therapeutic effect can be expected. Furthermore, although various metal complexes of porphyrin derivatives have been investigated as organic synthesis reaction catalysts, their application range may be dramatically expanded by improving their solubility.
【0006】[0006]
【発明が解決しようとする課題】上記したようにポルフ
ィン誘導体が水溶性である場合には種々の優れた効果が
期待できることから、本発明は水に対して優れた溶解性
を示すテトラフェニルポルフィン配糖体を提供すること
を目的とするものである。Since various excellent effects can be expected when the porphine derivative is water-soluble as described above, the present invention provides a tetraphenylporphine compound having excellent solubility in water. The purpose is to provide a glycoside.
【0007】[0007]
【課題を解決するための手段】本発明者らは、フォトケ
ミカルホールバーニングの新規な記録材料、フォトダイ
ナミックセラピーとしての治療剤、あるいは触媒として
の機能を有するテトラフェニルポルフィン金属錯体の前
駆物質を提供すべく、上記した化合物を鋭意研究を重ね
た結果、その合成に成功した。即ち、本発明のテトラフ
ェニルポルフィン配糖体化合物は、一般式(I)The present inventors have provided a novel recording material for photochemical hole burning, a therapeutic agent as a photodynamic therapy, or a precursor of a tetraphenylporphine metal complex having a function as a catalyst. Therefore, as a result of earnestly researching the above compound, its synthesis was successful. That is, the tetraphenylporphine glycoside compound of the present invention has the general formula (I)
【化1】[式中、Rは次式(II)[Wherein R is the following formula (II)
【化2】(但し、R1 、R2 およびR3 のうち一つがラ
クトースまたはマルトースのグリコシド残基であり、残
りは水素原子である。また、グリコシド残基のアノマー
性炭素上の置換立体配置がα−またはβ−のどちらかで
ある。)で示されるフェニルグリコシド残基を示す。]
で表される。Embedded image (wherein one of R 1 , R 2 and R 3 is a lactose or maltose glycoside residue, and the rest are hydrogen atoms. Also, the substitution configuration on the anomeric carbon of the glycoside residue is Is either α- or β-). ]
It is represented by.
【0008】一般式(I)で表されるテトラフェニルポ
ルフィン配糖体化合物は、文献に未記載の新規化合物で
ある。本発明の一般式(I)の化合物は、反応自体公知
の方法を組み合わせて合成できるが、以下の方法に依る
のが最も効率良く合成できる。即ち、ラクトースあるい
はマルトースを無水酢酸ナトリウムを触媒として無水酢
酸によりアセチル化して、オクタアセテートを得る。得
られたオクタアセテートはクロロホルムに溶解した後、
臭化水素酢酸溶液によってアノマー炭素をブロム化す
る。このブロミドとモノヒドロキシベンズアルデヒドの
ナトリウム塩とをアセトン中で反応させてフェニルグリ
コシドを得る。このフェニルグリコシドとピロールとを
乾燥ジクロロメタン中にて、三ふっ化ほう素ジエチルエ
ーテル錯体を触媒として反応させて上記一般式(I)で
示される化合物のアセチル化物を得る。次いで、メタノ
ール/ジクロロメタン中で、ナトリウムメトキシドを触
媒として脱アセチル化して上記一般式(I)で示される
化合物を得る。本発明の一般式(I)で示される化合物
は、常温常圧で暗赤色の固体であり、その可視スペクト
ルにはポルフィリンに特徴的なソーレ帯およびQ帯が認
められる。また、水に対して非常に良く溶解する。The tetraphenylporphine glycoside compound represented by the general formula (I) is a novel compound not described in the literature. The compound of the general formula (I) of the present invention can be synthesized by combining the methods known per se, but the following method is the most efficient. That is, lactose or maltose is acetylated with acetic anhydride using anhydrous sodium acetate as a catalyst to obtain octaacetate. The obtained octaacetate was dissolved in chloroform,
The anomeric carbon is brominated with a hydrobromide acetic acid solution. This bromide is reacted with sodium salt of monohydroxybenzaldehyde in acetone to obtain phenyl glycoside. This phenylglycoside and pyrrole are reacted in dry dichloromethane using a boron trifluoride diethyl ether complex as a catalyst to obtain an acetylated compound of the compound represented by the general formula (I). Then, it is deacetylated in methanol / dichloromethane with sodium methoxide as a catalyst to obtain the compound represented by the above general formula (I). The compound represented by the general formula (I) of the present invention is a dark red solid at room temperature and atmospheric pressure, and its visible spectrum shows the Sole band and Q band characteristic of porphyrin. It also dissolves very well in water.
【0009】ラクトース、マルトースの二糖が結合した
本発明のテトラフェニルポルフィン配糖体は、本発明者
らが先に発明したグルコースあるいはキシロースといっ
た単糖が結合したものと比較して、結合した二糖の糖鎖
のOH基による強い水素結合能力を有し、かつ水に対し
て高い溶解度を示し、飛躍的に水溶性が向上したもので
水に対して非常に良く溶解する。さらに、溶解性が改善
されることで、テトラフェニルポルフィン誘導体の金属
錯体も本発明の化合物から容易に得ることができる。The tetraphenylporphine glycoside of the present invention to which a disaccharide of lactose or maltose is bound is compared with the one to which a monosaccharide such as glucose or xylose previously invented by the present inventors is bound. It has a strong hydrogen-bonding ability due to the OH group of the sugar chain of sugar, exhibits high solubility in water, and has dramatically improved water solubility, and is very well soluble in water. Further, the metal complex of the tetraphenylporphine derivative can be easily obtained from the compound of the present invention by improving the solubility.
【0010】[0010]
【実施例】以下、実施例によって本発明をさらに詳細に
説明するが、一般式(I)で示される化合物の製造方法
は特に限定されず、本発明者らが先に出願した製造法を
もとに合成するのが好ましいが、個々のプロセスは他の
合成法によって得てもよい。[Examples] The present invention is described in more detail below with reference to Examples, but the production method of the compound represented by the general formula (I) is not particularly limited, and the production methods previously filed by the present inventors are also included. Preferably, the individual processes may be obtained by other synthetic methods.
【0011】実施例1 ラクトース・一水和物 10.00g( 0.278 mol)と酢酸ナ
トリウム5.00g(0.610 mol )に無水酢酸 30.60g(0.
2998 mol)を加え、 100℃で4時間攪拌した。反応液を
室温まで冷却し、メタノール5mlを加えて30分間攪
拌した。反応液に水を加え、ジクロロメタンで抽出し
た。このジクロロメタン抽出液を炭酸水素ナトリウム飽
和水溶液で洗浄した。さらに、水洗した後、ジクロロメ
タン層を分液した。このジクロロメタン溶液に、無水硫
酸ナトリウムを加えて乾燥させた。溶媒を留去後、エタ
ノールから再結晶した。この結晶を真空乾燥して、オク
タ−O−アセチルラクトース 14.94gを得た。EXAMPLE 1 10.00 g (0.278 mol) of lactose monohydrate, 5.00 g (0.610 mol) of sodium acetate and 30.60 g (0.
2998 mol) was added and the mixture was stirred at 100 ° C. for 4 hours. The reaction solution was cooled to room temperature, 5 ml of methanol was added, and the mixture was stirred for 30 minutes. Water was added to the reaction solution, which was extracted with dichloromethane. The dichloromethane extract was washed with a saturated aqueous solution of sodium hydrogen carbonate. Further, after washing with water, the dichloromethane layer was separated. Anhydrous sodium sulfate was added to this dichloromethane solution for drying. After distilling off the solvent, it was recrystallized from ethanol. The crystals were dried under vacuum to obtain 14.94 g of octa-O-acetyllactose.
【0012】三臭化リン5.59g(0.0206 mol)を酢酸14
mlに溶解し、氷冷下に攪拌しながら水1.01g(0.056
mol )を滴下した。滴下終了後、室温で30分間攪拌を続
けた。この溶液を、オクタ−O−アセチルラクトース 1
4.00g(0.0206mol)をクロロホルム 280mlに溶解し
た溶液に加え、室温で4時間攪拌した。反応液に水を加
え、ジクロロメタンで抽出した。この抽出液を水洗した
後、炭酸水素ナトリウム飽和水溶液で洗浄した。さら
に、水洗した後、ジクロロメタン層を分液し、無水硫酸
ナトリウムを加えて乾燥した。ジクロロメタンを留去し
た後、アセトン−ジエチルエーテルから再結晶してヘプ
タ−O−アセチルラクトシルブロミド 12.26gを得た。Phosphorus tribromide (5.59 g, 0.0206 mol) was added to acetic acid 14
1.01 g of water (0.056
mol) was added dropwise. After completion of dropping, stirring was continued at room temperature for 30 minutes. This solution was added to octa-O-acetyl lactose 1
4.00 g (0.0206 mol) was added to a solution of 280 ml of chloroform, and the mixture was stirred at room temperature for 4 hours. Water was added to the reaction solution, which was extracted with dichloromethane. The extract was washed with water and then with a saturated aqueous solution of sodium hydrogen carbonate. Furthermore, after washing with water, the dichloromethane layer was separated, and anhydrous sodium sulfate was added and dried. After distilling off dichloromethane, recrystallization from acetone-diethyl ether gave 12.26 g of hepta-O-acetyllactosyl bromide.
【0013】ヘプタ−O−アセチルラクトシルブロミド
10.00g(0.0143 mol)とp−ヒドロキシベンズアルデ
ヒドのナトリウム塩3.09g(0.0214 mol)にアセトン50
mlを加え、50℃で2時間攪拌した。反応液に水を加
え、ジクロロメタンで抽出した。この抽出液を5%炭酸
ナトリウム水溶液で洗浄した後、塩化ナトリウム飽和水
溶液で洗浄した。ジクロロメタン層を分液し、無水硫酸
ナトリウムを加えて乾燥した。ジクロロメタンを留去し
た後、真空乾燥してp−ホルミルフェニルヘプタ−O−
アセチルラクトシドの粗生成物を得た。この粗生成物を
三菱化成社製合成吸着剤SP207に吸着させた後、含
水メタノールにより溶離させた。フェニルグリコシドを
含む溶離液を減圧濃縮してp−ホルミルフェニルヘプタ
−O−アセチルラクトシド1.96gを得た。Hepta-O-acetyllactosyl bromide
50% acetone to 10.00 g (0.0143 mol) and sodium salt of p-hydroxybenzaldehyde 3.09 g (0.0214 mol)
ml was added, and the mixture was stirred at 50 ° C. for 2 hours. Water was added to the reaction solution, which was extracted with dichloromethane. The extract was washed with a 5% aqueous sodium carbonate solution and then with a saturated aqueous sodium chloride solution. The dichloromethane layer was separated, dried over anhydrous sodium sulfate. After distilling off dichloromethane, the residue was dried in vacuum and p-formylphenylhepta-O-
A crude product of acetyl lactoside was obtained. This crude product was adsorbed on a synthetic adsorbent SP207 manufactured by Mitsubishi Kasei Co., Ltd. and then eluted with hydrous methanol. The eluent containing phenylglycoside was concentrated under reduced pressure to obtain 1.96 g of p-formylphenylhepta-O-acetyllactoside.
【0014】p−ホルミルフェニルヘプタ−O−アセチ
ルラクトシド1.00g(0.00135 mol)とピロール92mg
( 0.00133 mol)を乾燥ジクロロメタンに溶解後、10分
間窒素置換した。三ふっ化ほう素・ジエチルエーテル錯
体ジエチルエーテル溶液30mgを加え、室温で2時間30
分反応させた。クロラニル0.33gを加えて、1時間還流
した。反応液を濃縮後、得られた粗生成物をシリカゲル
を用いるカラムクロマトグラフィーにより、15%アセト
ン−ジクロロメタンで溶出させて、目的物を分取した。
溶液を濃縮後、残渣をジクロロメタンに溶解し、メタノ
ールに注いで再沈澱させた。この沈澱を減圧濾過して沈
澱を回収した。沈澱を真空乾燥した後、再度上記のシリ
カゲルを用いるカラムクロマトグラフィーを行い上記一
般式(I)で示される化合物のアセチル化物0.19gを得
た。この固体20mgを50%メタノール−ジクロロメタン
2mlに溶解し、28%ナトリウムメチラートメタノール
溶液を1滴加えて室温で10分間反応させた。析出した固
体を減圧濾過し、真空乾燥して5,10,15,20−テトラ
キス(p−ラクトシルフェニル)ポルフィン15mgを得
た。1.00 g (0.00135 mol) of p-formylphenylhepta-O-acetyllactoside and 92 mg of pyrrole
(0.00133 mol) was dissolved in dry dichloromethane and then purged with nitrogen for 10 minutes. Boron trifluoride-diethyl ether complex Add 30 mg of diethyl ether solution, and let stand at room temperature for 2 hours 30
It was made to react for minutes. Chloranil (0.33 g) was added and the mixture was refluxed for 1 hour. After concentrating the reaction solution, the obtained crude product was subjected to column chromatography using silica gel, eluting with 15% acetone-dichloromethane to collect the target product.
After the solution was concentrated, the residue was dissolved in dichloromethane and poured into methanol for reprecipitation. This precipitate was filtered under reduced pressure to recover the precipitate. The precipitate was dried under vacuum, and column chromatography was again performed using the above silica gel to obtain 0.19 g of the acetylated compound of the general formula (I). 20 mg of this solid was dissolved in 2 ml of 50% methanol-dichloromethane, one drop of 28% sodium methylate methanol solution was added, and the mixture was reacted at room temperature for 10 minutes. The precipitated solid was filtered under reduced pressure and vacuum dried to obtain 15 mg of 5,10,15,20-tetrakis (p-lactosylphenyl) porphine.
【0015】実施例2 p−ヒドロキシベンズアルデヒドのナトリウム塩のかわ
りにo−ヒドロキシベンズアルデヒドのナトリウム塩を
用いて、上記実施例1と同様な合成法により5,10,1
5,20−テトラキス(o−ラクトシルフェニル)ポルフ
ィンを得た。Example 2 Using the sodium salt of o-hydroxybenzaldehyde instead of the sodium salt of p-hydroxybenzaldehyde, the same synthetic method as in Example 1 above was used.
5,20-Tetrakis (o-lactosylphenyl) porphine was obtained.
【0016】実施例3 p−ヒドロキシベンズアルデヒドのナトリウム塩のかわ
りにm−ヒドロキシベンズアルデヒドのナトリウム塩を
用いて、上記実施例1と同様な合成法により5,10,1
5,20−テトラキス(m−ラクトシルフェニル)ポルフ
ィンを得た。Example 3 Using the sodium salt of m-hydroxybenzaldehyde in place of the sodium salt of p-hydroxybenzaldehyde, the same synthetic method as in Example 1 above was used.
5,20-Tetrakis (m-lactosylphenyl) porphine was obtained.
【0017】実施例4 ラクトースのかわりにマルトースを原料とし、p−ヒド
ロキシベンズアルデヒドのナトリウム塩を用いて、上記
実施例1と同様な合成法により5,10,15,20−テトラ
キス(p−マルトシルフェニル)ポルフィンを得た。Example 4 5,10,15,20-tetrakis (p-maltosyl) was prepared by the same synthetic method as in Example 1 except that maltose was used as a raw material instead of lactose and sodium salt of p-hydroxybenzaldehyde was used. Phenyl) porphine was obtained.
【0018】実施例5 p−ヒドロキシベンズアルデヒドのナトリウム塩のかわ
りにo−ヒドロキシベンズアルデヒドのナトリウム塩を
用いて、上記実施例1と同様な合成法により5,10,1
5,20−テトラキス(o−マルトシルフェニル)ポルフ
ィンを得た。Example 5 Using the sodium salt of o-hydroxybenzaldehyde instead of the sodium salt of p-hydroxybenzaldehyde, the same synthetic method as in Example 1 above was used.
5,20-Tetrakis (o-maltosylphenyl) porphine was obtained.
【0019】実施例6 p−ヒドロキシベンズアルデヒドのナトリウム塩のかわ
りにm−ヒドロキシベンズアルデヒドのナトリウム塩を
用いて、上記実施例1と同様な合成法により5,10,1
5,20−テトラキス(m−マルトシルフェニル)ポルフ
ィンを得た。Example 6 Using the sodium salt of m-hydroxybenzaldehyde in place of the sodium salt of p-hydroxybenzaldehyde, the same synthetic method as in Example 1 above was used.
5,20-Tetrakis (m-maltosylphenyl) porphine was obtained.
【0020】上記各実施例で得られたテトラフェニルポ
ルフィンラクトース及びマルトース配糖体の物性を図1
〜6の 1H−核磁気共鳴スペクトル(NMR:重溶媒D
MSO)のチャートで示す。上記各実施例で得られた配
糖体はいずれも優れた水溶性を示した。The physical properties of the tetraphenylporphine lactose and maltose glycosides obtained in each of the above examples are shown in FIG.
~ 6 1 H-nuclear magnetic resonance spectrum (NMR: heavy solvent D
MSO) chart. The glycosides obtained in each of the above Examples all showed excellent water solubility.
【図1】実施例1で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。FIG. 1 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 1.
【図2】実施例2で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。FIG. 2 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 2.
【図3】実施例3で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。FIG. 3 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 3.
【図4】実施例4で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。FIG. 4 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 4.
【図5】実施例5で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。5 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 5. FIG.
【図6】実施例6で得られたテトラフェニルポルフィン
配糖体のNMRのチャートである。FIG. 6 is an NMR chart of the tetraphenylporphine glycoside obtained in Example 6.
【化3】 [Chemical 3]
【化4】 [Chemical 4]
Claims (1)
またはマルトースのグリコシド残基であり、残りは水素
原子である。また、グリコシド残基のアノマー性炭素上
の置換立体配置がα−またはβ−のどちらかである。)
で示されるフェニルグリコシド残基を示す。]で表され
る新規なテトラフェニルポルフィン配糖体化合物。1. A compound represented by the general formula (I): [Wherein R is the following formula (II): (However, one of R 1 , R 2 and R 3 is a lactose or maltose glycoside residue and the rest are hydrogen atoms. Further, the substitution configuration on the anomeric carbon of the glycoside residue is α- or It is either β-.)
Represents a phenylglycoside residue represented by. ] The novel tetraphenylporphine glycoside compound represented by these.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03301053A JP3076883B2 (en) | 1991-10-21 | 1991-10-21 | A novel tetraphenylporphine glycoside |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03301053A JP3076883B2 (en) | 1991-10-21 | 1991-10-21 | A novel tetraphenylporphine glycoside |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05112593A true JPH05112593A (en) | 1993-05-07 |
| JP3076883B2 JP3076883B2 (en) | 2000-08-14 |
Family
ID=17892295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP03301053A Expired - Fee Related JP3076883B2 (en) | 1991-10-21 | 1991-10-21 | A novel tetraphenylporphine glycoside |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3076883B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020621A1 (en) * | 2000-09-08 | 2002-03-14 | San-Ei Gen F.F.I.,Inc. | Tetraphenylporphyrin derivatives and compositions comprising the same |
| JP2014528918A (en) * | 2011-07-22 | 2014-10-30 | バイオリテック ファーマ マーケティング リミテッド | Sugar-substituted dihydroxy-chlorins and β-functionalized chlorins for antibacterial photodynamic therapy |
-
1991
- 1991-10-21 JP JP03301053A patent/JP3076883B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020621A1 (en) * | 2000-09-08 | 2002-03-14 | San-Ei Gen F.F.I.,Inc. | Tetraphenylporphyrin derivatives and compositions comprising the same |
| JP2014528918A (en) * | 2011-07-22 | 2014-10-30 | バイオリテック ファーマ マーケティング リミテッド | Sugar-substituted dihydroxy-chlorins and β-functionalized chlorins for antibacterial photodynamic therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3076883B2 (en) | 2000-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU221102B1 (en) | Beta,beta'-dihydroxy meso-substituted chlorins, bacteriochlorins, isobacteriochlorins, and process for preparing thereof | |
| CN118165048A (en) | Method for preparing oxy-glycoside compound and application of glycosyl donor in preparing oxy-glycoside compound | |
| KR100667644B1 (en) | Nitroimidazole-supported porphyrin complex | |
| EP2940021A1 (en) | Cyanine dye compound and preparation method therefor, and dual-function agent for photodynamic therapy and preparation method therefor | |
| Jeffery | Palladium-catalysed direct synthesis of optically active dienols | |
| JPH01308243A (en) | Production method of 4-demethoxydaunomycinone | |
| US7157432B2 (en) | Tetraphenylbacteriochlorin derivatives and compositions containing the same | |
| JP3076883B2 (en) | A novel tetraphenylporphine glycoside | |
| JPH0249314B2 (en) | ||
| CN109206469B (en) | Glycyrrhetinic acid derivative and preparation method and application thereof | |
| JPH0786109B2 (en) | Pheophorbide derivative | |
| JP2571950B2 (en) | Cyclopentenone derivatives and their production | |
| GB2238540A (en) | 13-deoxy-4'-deoxy-4'-iodoanthracyclines and intermediates therefor | |
| JP3564640B2 (en) | Novel hematoporphyrins and diagnostic agents for MRI | |
| JPH05247081A (en) | New tetraphenyulporphyrin glycoside and its production | |
| CN114773411B (en) | Synthesis method of lactose fullerene anti-tumor lead compound | |
| JPS6024102B2 (en) | Method for producing 5-fluorouracil derivatives | |
| JPH04247096A (en) | 13-dihydro-3'-(2-alkoxy-4-morpholinyl)- anthracyclin | |
| WO2002020621A1 (en) | Tetraphenylporphyrin derivatives and compositions comprising the same | |
| JP2663295B2 (en) | Hexadienoic acid derivative and method for producing the same | |
| CN118598921A (en) | A kind of synthetic method of ellagic acid glycoside derivative | |
| CN117659018A (en) | Chiral C1 symmetric imidazole-pyridine-imidazolinone tridentate nitrogen ligand and its synthesis and application | |
| CN117964685A (en) | Antibody drug conjugates and intermediates thereof, preparation methods and applications | |
| Zao-ying et al. | Synthesis of novel tailed porphyrins with covalently linked saccharide | |
| JPS6045587A (en) | Novel oligomannoside and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |